AIDS kills over 1.5 million people a year globally. Current HIV drugs pose many challenges. This presentation shows that nano-encapsulation of HIV drugs achieves controlled and steady drug release, and
reduced dosing frequency.
Reference:
Tshweu, L., Katata, L., Naidoo, S., Kalombo, L. and Swai, H. Design and formulation of nano-sized spray dried Efavirenz-Part 1: Influence of formulation parameters. 4th CSIR Biennial Conference: Real problems relevant solutions, CSIR, Pretoria, 9-10 October 2012
Tshweu, L., Katata, L., Naidoo, S., Kalombo, L., & Swai, H. (2012). Design and formulation of nano-sized spray dried Efavirenz-Part 1: Influence of formulation parameters. http://hdl.handle.net/10204/6262
Tshweu, L, L Katata, Saloshnee Naidoo, Lonji Kalombo, and H Swai. "Design and formulation of nano-sized spray dried Efavirenz-Part 1: Influence of formulation parameters." (2012): http://hdl.handle.net/10204/6262
Tshweu L, Katata L, Naidoo S, Kalombo L, Swai H, Design and formulation of nano-sized spray dried Efavirenz-Part 1: Influence of formulation parameters; 2012. http://hdl.handle.net/10204/6262 .
ResearchSpace
